PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Cassava Sciences, Inc. (SAVA)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US14817C1071

CUSIP

14817C107

Sector

Healthcare

IPO Date

Jul 14, 2000

Highlights

Market Cap

$133.75M

EPS (TTM)

-$1.38

Gross Profit (TTM)

-$611.00K

EBITDA (TTM)

-$112.18M

Year Range

$2.23 - $42.20

Target Price

$116.00

Short %

35.16%

Short Ratio

6.35

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
SAVA vs. ALZN SAVA vs. NVDA SAVA vs. PEP SAVA vs. VTI SAVA vs. AMZN SAVA vs. VOO
Popular comparisons:
SAVA vs. ALZN SAVA vs. NVDA SAVA vs. PEP SAVA vs. VTI SAVA vs. AMZN SAVA vs. VOO

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Cassava Sciences, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-91.08%
9.31%
SAVA (Cassava Sciences, Inc.)
Benchmark (^GSPC)

Returns By Period

Cassava Sciences, Inc. had a return of 17.80% year-to-date (YTD) and -87.63% in the last 12 months. Over the past 10 years, Cassava Sciences, Inc. had an annualized return of -14.79%, while the S&P 500 had an annualized return of 11.31%, indicating that Cassava Sciences, Inc. did not perform as well as the benchmark.


SAVA

YTD

17.80%

1M

1.09%

6M

-91.09%

1Y

-87.63%

5Y*

-18.33%

10Y*

-14.79%

^GSPC (Benchmark)

YTD

4.46%

1M

2.46%

6M

9.31%

1Y

23.49%

5Y*

13.03%

10Y*

11.31%

*Annualized

Monthly Returns

The table below presents the monthly returns of SAVA, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20250.85%17.80%
20246.40%-4.05%-11.71%9.17%-0.54%-43.94%79.92%29.21%2.51%-12.32%-85.12%-38.54%-89.52%
2023-5.21%-11.79%-2.35%-3.73%-2.20%7.97%-10.36%-4.60%-20.65%21.09%3.37%8.07%-23.80%
20221.26%-3.93%-12.63%-43.81%46.62%-8.10%-41.93%57.56%62.53%-12.86%-4.42%-15.19%-32.40%
2021190.62%145.11%-7.47%4.12%15.21%58.46%-18.62%-18.24%9.20%-30.53%24.02%-18.30%540.76%
202056.73%-31.17%-26.74%85.89%-71.99%43.93%2.92%-0.95%266.56%-28.67%-5.97%-11.66%31.15%
201937.65%0.85%9.32%-14.73%-0.00%10.00%11.57%-17.04%7.14%9.17%12.98%251.35%511.76%
201875.25%-7.28%9.08%13.54%23.73%-79.32%8.74%-54.46%-0.98%16.83%-2.54%-26.09%-78.75%
2017-1.75%1.79%56.14%-4.49%-36.81%10.37%-17.83%-5.87%26.79%-13.27%13.88%-0.50%0.25%
2016-7.43%13.58%21.20%8.52%-3.72%-6.01%23.29%-11.48%-58.16%-44.00%14.29%-10.94%-67.43%
2015-2.96%-3.55%-0.53%7.94%-3.43%-12.18%9.25%-2.65%-0.54%1.09%8.11%-12.50%-13.79%
2014-14.40%35.82%-2.65%3.45%-13.01%16.16%-26.78%0.24%-7.35%-55.50%4.02%12.15%-58.23%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of SAVA is 11, meaning it’s performing worse than 89% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of SAVA is 1111
Overall Rank
The Sharpe Ratio Rank of SAVA is 1414
Sharpe Ratio Rank
The Sortino Ratio Rank of SAVA is 1919
Sortino Ratio Rank
The Omega Ratio Rank of SAVA is 1616
Omega Ratio Rank
The Calmar Ratio Rank of SAVA is 22
Calmar Ratio Rank
The Martin Ratio Rank of SAVA is 22
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Cassava Sciences, Inc. (SAVA) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for SAVA, currently valued at -0.64, compared to the broader market-2.000.002.00-0.641.74
The chart of Sortino ratio for SAVA, currently valued at -0.51, compared to the broader market-4.00-2.000.002.004.006.00-0.512.35
The chart of Omega ratio for SAVA, currently valued at 0.91, compared to the broader market0.501.001.502.000.911.32
The chart of Calmar ratio for SAVA, currently valued at -0.90, compared to the broader market0.002.004.006.00-0.902.61
The chart of Martin ratio for SAVA, currently valued at -1.80, compared to the broader market0.0010.0020.0030.00-1.8010.66
SAVA
^GSPC

The current Cassava Sciences, Inc. Sharpe ratio is -0.64. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Cassava Sciences, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00SeptemberOctoberNovemberDecember2025February
-0.64
1.74
SAVA (Cassava Sciences, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Cassava Sciences, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-97.95%
0
SAVA (Cassava Sciences, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Cassava Sciences, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Cassava Sciences, Inc. was 99.18%, occurring on Dec 24, 2018. Recovery took 637 trading sessions.

The current Cassava Sciences, Inc. drawdown is 97.95%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.18%Sep 8, 20004602Dec 24, 2018637Jul 7, 20215239
-98.32%Jul 29, 2021887Feb 7, 2025
-35.69%Jul 20, 200026Aug 24, 20009Sep 7, 200035
-24.44%Jul 9, 20216Jul 16, 20213Jul 21, 20219
-13.71%Jul 17, 20002Jul 18, 20001Jul 19, 20003

Volatility

Volatility Chart

The current Cassava Sciences, Inc. volatility is 15.03%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%50.00%100.00%150.00%200.00%SeptemberOctoberNovemberDecember2025February
15.03%
3.07%
SAVA (Cassava Sciences, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Cassava Sciences, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Cassava Sciences, Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab